https://doi.org/10.1158/1535-7163.mct-06-0025
Y
Yuko Takano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
603
Citations
12
h-index
16
i10-index
Yuko Takano is an academic researcher from Nagoya University Hospital. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Lung Cancer Treatments and Mutations. The author has an h-index of 12, co-authored 57 publications.
ORCID: 0000-0002-3753-7683Papers by this author
worksThe determinants of sensitivity and acquired resistance to gemcitabine differ in non–small cell lung cancer: a role of <i>ABCC5</i> in gemcitabine sensitivity
2006 · Molecular Cancer Therapeutics · 96 citations
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
2023 · Breast Cancer · 53 citations
https://doi.org/10.1007/s12282-023-01505-x
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
2021 · International Cancer Conference Journal · 6 citations
https://doi.org/10.1007/s13691-021-00515-w
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–positive, HER2-negative advanced or metastatic breast cancer
2025 · Breast Cancer · 3 citations
https://doi.org/10.1007/s12282-025-01713-7
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast
2025 · Breast Cancer · 1 citations
https://doi.org/10.1007/s12282-025-01706-6
Prognostic impact of ER-staining patterns and heterogeneity of ER positive HER2 negative breast cancer
2025 · Breast Cancer · 0 citations
https://doi.org/10.1007/s12282-025-01716-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat